MedPath

Comparison of Hemodynamic Changes in Administration of Ondansetron and Metoclopramide in Preventing Post Operative Nausea and Vomiting after Strabism Surgery

Phase 2
Conditions
Strabism.
Strabism, unspecified
Registration Number
IRCT201101052496N5
Lead Sponsor
Research Vice chancellor of Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
96
Inclusion Criteria

Patients with average age of 6-12y/o, ASA (American Society of Anesthesiologists) physical status I and II candidated for strabism surgery with general anesthesia
Exclusion criteria: The patients who received antiemetics during previous 24 hours, the patients suffering from liver, renal, gastrointestinal disorders and motion sickness

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea. Timepoint: After 0, 2, 6 and 24 hours of surgury. Method of measurement: Zero for not having nausea - 1, for mild nausea- 2, for moderate nausea and 3 for sever nausea.
Secondary Outcome Measures
NameTimeMethod
Vomiting. Timepoint: After 0, 2, 6 and 24 hours of surgury. Method of measurement: Zero for the patients not experiencing vomiting, 1 for the little vomiting, 2 for vomiting gastric contents and 3 for vomiting food particles.
© Copyright 2025. All Rights Reserved by MedPath